ALS Untangled Series Ep. 56 - Sodium Chlorite

CReATe Podcast
15/11/2023 22 min
ALS Untangled Series Ep. 56 - Sodium Chlorite

Listen "ALS Untangled Series Ep. 56 - Sodium Chlorite"

Descargar episodio Ver en sitio original

Episode Synopsis

Sodium chlorite is an experimental drug targeting macrophage activation. It exists in different formulations. An oral formulation has potentially deadly side effects. An IV formulation called NP001 has been in recent trials targeting a subset of people with ALS. Here we review the interesting development of this product and where we expect that to go in the near future.

More episodes of the podcast CReATe Podcast

ALS Untangled Series Ep. 62 - Ashwagandha 20/10/2025
CReATe Author Series Ep. 16 - Dr. Johnathan Cooper-Knock on Exercise and ALS 24/09/2025
ALS Untangled Series Ep. 61 - Zinc 09/09/2025
CReATe Author Series Ep. 15 - Drs. Terry Heiman-Patterson and Michael Benatar on Clinical Guidance for ALS/FTD at-risk carriers 02/06/2025
CReATe Author Series Ep. 14 - Drs. Ruben van Eijk and Michael Benatar on Phase 2 Trials and ALS 01/05/2025
CReATe Author Series Ep. 13 - Dr. Benatar on Prognostic Markers and ALS 18/02/2025
CReATe Author Series Ep. 12 - Drs. Jesse Crayle and Evadnie Rampersaud on Genetics and ALS Reversal Phenotype 02/01/2025
ALS Untangled Series Ep. 60 - Nuedexta 04/12/2024
ALS Untangled Series Ep. 59 - Lions Mane 04/11/2024
ALS Untangled Series Ep. 58 - Insulin 01/10/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA